Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-CoV-2 Spike S1 Protein (RBD) (His tag,AVI tag,Biotin)

This Recombinant SARS-CoV-2 Spike S1 protein is expressed in HEK-293 Cells and has been mentioned in 5+ publications.
Catalog No. ABIN6952456

Quick Overview for SARS-CoV-2 Spike S1 Protein (RBD) (His tag,AVI tag,Biotin) (ABIN6952456)

Target

See all SARS-CoV-2 Spike S1 Proteins
SARS-CoV-2 Spike S1

Protein Type

Recombinant

Origin

  • 97
  • 6
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Source

  • 95
  • 3
  • 2
  • 1
  • 1
  • 1
HEK-293 Cells

Purity

> 90 % as determined by SDS-PAGE. > 90 % as determined by SEC-MALS.
  • Protein Characteristics

    RBD

    Purification tag / Conjugate

    This SARS-CoV-2 Spike S1 protein is labelled with His tag,AVI tag,Biotin.

    Sequence

    AA 319-541

    Specificity

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

    Characteristics

    Biotinylated 2019-nCoV (COVID-19) S protein RBD, His,Avitag (MALS verified) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Phe 541 (Accession # QHD43416.1). Predicted N-terminus: Arg 319 This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag.

    Endotoxin Level

    Less than 1.0 EU per μg by the LAL method.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    The protein has a calculated MW of 28.7 kDa. The protein migrates as 34-37 kDa under reducing (R) condition due to glycosylation.

    Comment

    Ready-to-use AvitagTM biotinylated protein:
    The product is exclusively produced using the AvitagTM technology. Briefly, a unique 15 amino acid peptide, the Avi tag, is introduced into the recombinant protein during expression vector construction. The single lysine residue in the Avi tag is enzymatically biotinylated by the E. Coli biotin ligase BirA.

    This single-point enzymatic labeling technique brings many advantages for commonly used binding assays. The biotinylation happens on the lysine residue of Avi tag, and therefore does NOT interfere with the target protein's natural binding activities. In addition, when immobilized on an avidin-coated surface, the protein orientation is uniform because the position of the Avi tag in the protein is precisely controlled.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    PBS, pH 7.4

    Handling Advice

    Please avoid repeated freeze-thaw cycles.

    Storage

    -20 °C,-80 °C

    Storage Comment

    For long term storage, the product should be stored at lyophilized state at -20°C or lower. This product is stable aftr storage at: -20°C to -70°C for 12 months in lyophilized state, -70°C for 3 months under sterile conditions after reconstitution.
  • Dogan, Kozhaya, Placek, Gunter, Yigit, Hardy, Plassmeyer, Coatney, Lillard, Bukhari, Kleinberg, Hayes, Arditi, Klapper, Merin, Liang, Gupta, Alpan, Unutmaz: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." in: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).

    Bell, Powell, Rodriguez, Cochran, Kim: "Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library." in: Protein science : a publication of the Protein Society, Vol. 30, Issue 4, pp. 716-727, (2021) (PubMed).

    Prieto-Fernández, Egia-Mendikute, Vila-Vecilla, Bosch, Barreira-Manrique, Lee, García-Del Río, Antoñana-Vildosola, Jiménez-Lasheras, Moreno-Cugnon, Jiménez-Barbero, Berra, Ereño-Orbea, Palazon: "Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate." in: Emerging microbes & infections, Vol. 10, Issue 1, pp. 1065-1076, (2021) (PubMed).

    Mulligan, Lyke, Kitchin, Absalon, Gurtman, Lockhart, Neuzil, Raabe, Bailey, Swanson, Li, Koury, Kalina, Cooper, Fontes-Garfias, Shi, Türeci, Tompkins, Walsh, Frenck, Falsey, Dormitzer, Gruber, Şahin et al.: "Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. ..." in: Nature, Vol. 586, Issue 7830, pp. 589-593, (2020) (PubMed).

    Guo, Yao, Yang, Zhang, Qi, Gou, Xi, Liu, Zhang, Cheng, Wang, Rong, Chen, Kong: "Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection." in: Chemical engineering journal (Lausanne, Switzerland : 1996), pp. 127742, (2020) (PubMed).

  • Target

    SARS-CoV-2 Spike S1

    Target Type

    Viral Protein

    Background

    It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

    Molecular Weight

    28.2 kDa

    Gene ID

    43740568

    UniProt

    P0DTC2
You are here:
Chat with us!